🎗️ OncologyInjection (IV)
Breyanzi
Lisocabtagene Maraleucel
CD19-directed CAR T-cell therapy for relapsed/refractory large B-cell lymphoma, CLL, and follicular lymphoma.
Form
Injection (IV)
Uses
3
Side effects
4
Category
Oncology
01
What is Breyanzi used for?
- Relapsed/refractory large B-cell lymphoma
- CLL/SLL
- Follicular lymphoma
02
Lisocabtagene Maraleucel side effects
Common side effects of Lisocabtagene Maraleucel include:
Cytokine release syndrome
Neurotoxicity (ICANS)
Infections
Prolonged cytopenias
CommonModerateLess common
03
Lisocabtagene Maraleucel warnings & precautions
- Black box: CRS and neurological toxicities
- REMS required
- Secondary malignancies including T-cell lymphoma reported
Loading FDA data…
04
Frequently asked questions
05
Related medications
Share
Share this drug info.
Help friends and family understand Breyanzi in plain language.
Disclaimer: This information is sourced from the FDA openFDA database and is provided for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your physician or pharmacist before starting or changing medication.